In Vivo is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

GE Medical and Amersham Sharpen Their Molecular Image

Executive Summary

With a surge in interest in molecular imaging, GE Medical Systems has been on the prowl for new technologies that improve performance of its PET and SPECT systems, so that clinicians can obtain information at the subcellular level. Amersham Health, too, has been been looking for better systems to help improve distribution and performance of its radiopharmaceutical labeling agents. Now the two are joining forces to create a next-generation compound for PET using new, easier-to-use chemistries.
Advertisement

Related Content

GE's Pharma Ambitions Lead to a Lilly Deal
GE's Personalized Play for Amersham
GE's Personalized Play for Amersham
GE Buys Instrumentarium: A Big Deal May Boost Digital Mammography
Amersham's Push for High-Value Diagnostics
Amersham's Push for High-Value Diagnostics
Preparing Molecular Imaging's Future
Preparing Molecular Imaging's Future
GE-Genometrix: Dx Imaging Meets Genomics

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

IV001573

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel